HIGHLIGHTS
- who: Jessica E. Holder et al. from the Cedars Sinai Medical Center, United States University of California, Los Angeles have published the research: The use of nanoparticles for targeted drug delivery in non-small cell lung cancer, in the Journal: (JOURNAL)
- what: Although this trial has concluded, outcome measures are still being monitored. This study shows how drugs can be targeted to tumors using pH-sensitive release methods to increase drug delivery to tumors and decrease the effects of the drug in healthy tissue.
- future: Overall survival and progression free survival were not . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.